Source data for Berger et al. Pre-clinical proof of principle for orally delivered Th17 antagonist miniproteins

Published: 4 April 2024| Version 1 | DOI: 10.17632/2n9gstvrsy.1
Contributor:
Stephanie Berger

Description

Source data for Berger et al. Pre-clinical proof of principle for orally delivered Th17 antagonist miniproteins.

Files

Steps to reproduce

Please see associated manuscript for detailed methods.

Categories

Cell Signaling, Biophysical Chemistry, Protein Engineering, Enzyme-Linked Immunosorbent Assay, Efficacy Study, Protein Binding

Funding

Audacious Project

Howard Hughes Medical Institute

Washington Research Foundation

Center for Washington Entrepreneurial Research Evaluation & Commercialization Hub (WE-REACH)

Mopac Biologics, Inc.

National Institutes of Health

R01 GM092802, R01 AR067288, R35 GM147414, P30 GM124165

Licence